To use all functions of this page, please activate cookies in your browser.
Scientists prefer to found companies as part-time entrepreneurs
Start-ups by researchers are significantly more stable than start-ups in general
Infrastructure at the university promoting start-ups and contacts in the business community has a positive effect on the start-up success of scientists. This is the result of a study by the IfM Bonn, which examined the start-up behaviour of academics at German universities over a period of seven years.
The study showed that every third person interested in founding a company in 2013 realised it in 2020. "The newly founded companies are innovative. However, 80% of the founders carry out their self-employment as a secondary occupation - and not all of them intend to run it as a full-time business later," reports IfM researcher Dr Teita Bijedić. Together with her colleagues, she has surveyed around 7,300 academics at German universities about their start-up activities in recent years.
The respondents reported a lack of commercial knowledge and a lack of market knowledge as the biggest obstacles to start a business. Especially those interested in founding a company in the so-called STEM areas (mathematics, computer science, natural science, technology) reported these obstacles commonly.
Those who finally found a company did not regret this decision: around nine in ten respondents stated that they would repeat the step into self-employment. In 2020, two-thirds of the start-ups from 2013 were still active on the market - the general survival rate of start-ups is 37% after five years, according to calculations by the IfM Bonn.
In addition, life satisfaction is also significantly higher among the self-employed than among scientists who are not self-employed. However, satisfaction with income was higher among the group of scientists who did not run a business.
- 1Designer cytokine makes paralyzed mice walk again
- 2New ion trap to create the world's most accurate mass spectrometer
- 3COVID-19 has multiple faces
- 4A prognostic Alzheimer’s disease blood test in the symptom-free stage
- 5Detect neurodegenerative diseases such as Alzheimer's by a simple eye scan?
- 6New and highly efficient method for SARS-CoV-2 mutation analysis
- 7Nanocrystals that eradicate bacteria biofilm
- 8Why remdesivir does not fully stop the coronavirus
- 9Detecting COVID-19 antibodies in 10-12 seconds
- 10Single-cell test can reveal precisely how drugs kill cancer cells
- XPhyto signs transformative acquisition agreement with 3a-diagnostics
- Merck Invests € 270 Million in a New Research Center and Vocational & Advanc ...
- BioNTech to Acquire Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manu ...
- Sartorius acquires majority stake in CellGenix
- Cytiva acquires Intermountain Life Sciences